DeepMed Research

H. Lee Moffitt Cancer Center and Research Institute, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Early Supportive Care and Nutritional Support in Adults With Pancreatic Cancer

Not Applicable

Active, not recruiting

Conditions: Pancreatic Cancer

Interventions: Behavioral: Fitbit Data Collection
Behavioral: Nutrition Counseling
Behavioral: Fact G Survey
Behavioral: General Anxiety Disorder (GAD)-7
Behavioral: Patient Health Questionnaire (PHQ)-9

First Posted Date: 2022-06-30

Last Posted Date: 2025-05-07

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 50

Registration Number: NCT05438927

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients

Not Applicable

Active, not recruiting

Conditions: GastroEsophageal Cancer

Interventions: Behavioral: Fitbit Data Collection
Behavioral: Nutrition Counseling
Behavioral: Survey

First Posted Date: 2022-06-30

Last Posted Date: 2025-05-07

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 23

Registration Number: NCT05438940

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

"COACH" Study: Individualized COaching in Young Adult Cancer Survivors to Encourage Healthy Behaviors

Active, not recruiting

Conditions: Health Behavior

Interventions: Behavioral: Digital Diet Diary
Behavioral: NHANES Food Frequency Questionnaire (FFQ)
Behavioral: Fitbit data collection
Behavioral: Quality of Life questionnaire
Behavioral: Functional Assessment of Cancer Therapy - General (FACT-G) Questionnaire
Behavioral: Godin Exercise Leisure-Time questionnaire
Behavioral: Zoom interviews

First Posted Date: 2022-06-28

Last Posted Date: 2025-04-13

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 100

Registration Number: NCT05434702

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer

Phase 1

Recruiting

Conditions: HER2-positive Breast Cancer

Interventions: Biological: Dendritic Cell (DC1) Vaccine
Drug: Trastuzumab
Drug: Pepinemab
Biological: T-Cell therapy

First Posted Date: 2022-05-18

Last Posted Date: 2025-03-13

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 28

Registration Number: NCT05378464

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Caregiver Protocol for Remotely Improving, Monitoring, and Extending Quality of Life

Not Applicable

Completed

Conditions: Quality of Life
Stress
Sleep Disturbance

Interventions: Other: Remote health coaching to improve self-care behaviors

First Posted Date: 2022-05-18

Last Posted Date: 2023-01-20

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 33

Registration Number: NCT05379933

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-free

Not Applicable

Completed

Conditions: Tobacco Use
Lung Cancer
Smoking

Interventions: Drug: Nicotine patch and lozenges
Behavioral: Telephone counseling sessions
Behavioral: Access to a web-based video
Behavioral: Florida Tobacco Quitline

First Posted Date: 2022-05-05

Last Posted Date: 2025-03-27

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 21

Registration Number: NCT05362318

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Early Phase 1

Active, not recruiting

Conditions: Cutaneous Melanoma
Cutaneous Squamous Cell Carcinoma
Merkel Cell Carcinoma

Interventions: Other: Exercise
Drug: Checkpoint Blockade, Immune

First Posted Date: 2022-05-03

Last Posted Date: 2025-04-11

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 22

Registration Number: NCT05358938

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab

Phase 2

Recruiting

Conditions: HER2-positive Breast Cancer

Interventions: Biological: HER-2 pulsed DC1
Drug: Trastuzumab
Drug: Pertuzumab
Drug: Paclitaxel
Procedure: Resection surgery

First Posted Date: 2022-04-13

Last Posted Date: 2025-03-03

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 53

Registration Number: NCT05325632

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)

Early Phase 1

Active, not recruiting

Conditions: Large Granular Lymphocyte Leukemia

Interventions: Drug: Siltuximab

First Posted Date: 2022-04-07

Last Posted Date: 2025-02-03

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 6

Registration Number: NCT05316116

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer

Phase 1

Recruiting

Conditions: Ovarian Cancer

Interventions: Drug: Follicle Stimulating Hormone Receptor T Cells

First Posted Date: 2022-04-07

Last Posted Date: 2025-05-21

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 10

Registration Number: NCT05316129

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy